Culmination Pharmaceuticals Private Limited - Company Profile

It is a healthcare private limited company based in Kolkata, West Bengal, India, established in 2015.
2015 Kolkata, West Bengal, India Struck Off
Last Updated:
Access Report
About Culmination Pharmaceuticals Private Limited

Culmination Pharmaceuticals Private Limited, a struck off private limited company, was established on 05 January 2015 in Kolkata, West Bengal, India. Engaging in other hospital and medical care activities within the hospital and medical care sector, it holds CIN: U74900WB2015PTC204812. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Sweta Saraf (Director), Manoj Kumar Bajaj (Director). Its latest AGM occurred on 29 September 2018, with the balance sheet filed on 31 March 2018. It is based at Pratibha Enclave 23, Canal Street, 3Rd Floor, Flat No. 30, 7, Kolkata, West Bengal, 700048.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74900WB2015PTC204812

  • Registration Number

    204812

  • Incorporation Date

    05 January 2015

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kolkata

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Year, 1 Month
  • Last Filing with ROC 31 Mar 2018
Company report

Culmination Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Culmination Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Culmination Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Sweta Saraf Director 05 Jan 2015 Current
Manoj Kumar Bajaj Director 05 Jan 2015 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Culmination Pharmaceuticals.

Culmination Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Culmination Pharmaceuticals revenue growth over time
Culmination Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Culmination Pharmaceuticals?

In 2017, Culmination Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Culmination Pharmaceuticals?

Unlock and access historical data on people associated with Culmination Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Culmination Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Culmination Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Culmination Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Culmination Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Culmination Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Kolkata. was documented.

  • Director Appointment

    The activity Sweta Saraf was appointed as a Director was appointed as a Director on 05 Jan 2015 & has been associated with this company since 11 years 1 month . was completed.

  • Director Appointment

    The activity Manoj Kumar Bajaj was appointed as a Director was appointed as a Director on 05 Jan 2015 & has been associated with this company since 11 years 1 month . was completed.

  • Company Incorporation

    Progress on Culmination Pharmaceuticals Private Limited was registered on 05 Jan 2015 with Roc Kolkata & aged 11 years 1 month as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Culmination Pharmaceuticals Private Limited?

The CIN of Culmination Pharmaceuticals Private Limited is U74900WB2015PTC204812.

Where is Culmination Pharmaceuticals Private Limited headquartered?

Culmination Pharmaceuticals Private Limited is headquartered at Pratibha Enclave 23, Canal Street, 3Rd Floor, Flat No. 30, 7, Kolkata, West Bengal, 700048.

When was Culmination Pharmaceuticals Private Limited incorporated?

Culmination Pharmaceuticals Private Limited was incorporated on 05 January 2015.

Who are the current directors of Culmination Pharmaceuticals Private Limited?

The current directors of Culmination Pharmaceuticals Private Limited are

What is the primary industry of Culmination Pharmaceuticals Private Limited?

The primary industry of Culmination Pharmaceuticals Private Limited is Hospital And Medical Care.

Is Culmination Pharmaceuticals Private Limited a listed company?

Culmination Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Culmination Pharmaceuticals Private Limited?

The authorized capital of Culmination Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Culmination Pharmaceuticals Private Limited?

The compliance status of Culmination Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available